Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nature's Sunshine Products Return on Tangible Equity 2011-2025 | NATR

Current and historical return on tangible equity values for Nature's Sunshine Products (NATR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Nature's Sunshine Products Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-09-30 $0.02B $0.17B 9.10%
2025-06-30 $0.01B $0.16B 8.55%
2025-03-31 $0.01B $0.17B 6.18%
2024-12-31 $0.01B $0.16B 4.38%
2024-09-30 $0.02B $0.16B 10.02%
2024-06-30 $0.02B $0.16B 9.55%
2024-03-31 $0.02B $0.16B 10.31%
2023-12-31 $0.02B $0.16B 9.87%
2023-09-30 $0.01B $0.15B 5.38%
2023-06-30 $0.01B $0.15B 3.42%
2023-03-31 $0.00B $0.15B 2.76%
2022-12-31 $0.00B $0.15B 0.00%
2022-09-30 $0.01B $0.14B 7.37%
2022-06-30 $0.02B $0.14B 10.61%
2022-03-31 $0.02B $0.15B 14.52%
2021-12-31 $0.03B $0.16B 19.43%
2021-09-30 $0.02B $0.15B 14.84%
2021-06-30 $0.02B $0.15B 16.19%
2021-03-31 $0.02B $0.14B 15.73%
2020-12-31 $0.02B $0.16B 15.28%
2020-09-30 $0.02B $0.15B 12.41%
2020-06-30 $0.01B $0.14B 8.37%
2020-03-31 $0.01B $0.13B 6.26%
2019-12-31 $0.01B $0.13B 5.60%
2019-09-30 $0.00B $0.13B 2.44%
2019-06-30 $0.00B $0.12B 2.46%
2019-03-31 $0.00B $0.12B 0.00%
2018-12-31 $0.00B $0.12B -1.65%
2018-09-30 $-0.02B $0.12B -13.25%
2018-06-30 $-0.02B $0.12B -12.12%
2018-03-31 $-0.02B $0.12B -11.83%
2017-12-31 $-0.01B $0.12B -10.00%
2017-09-30 $0.00B $0.14B -2.26%
2017-06-30 $0.00B $0.13B -0.74%
2017-03-31 $0.00B $0.13B 1.47%
2016-12-31 $0.00B $0.13B 1.46%
2016-09-30 $0.01B $0.14B 9.42%
2016-06-30 $0.01B $0.14B 8.82%
2016-03-31 $0.01B $0.14B 8.89%
2015-12-31 $0.02B $0.14B 11.94%
2015-09-30 $0.01B $0.13B 6.06%
2015-06-30 $0.01B $0.13B 4.53%
2015-03-31 $0.01B $0.13B 4.68%
2014-12-31 $0.01B $0.13B 8.08%
2014-09-30 $0.02B $0.14B 13.59%
2014-06-30 $0.02B $0.12B 18.22%
2014-03-31 $0.02B $0.11B 20.72%
2013-12-31 $0.02B $0.10B 16.07%
2013-09-30 $0.02B $0.10B 17.43%
2013-06-30 $0.02B $0.12B 18.03%
2013-03-31 $0.02B $0.12B 19.78%
2012-12-31 $0.02B $0.12B 22.75%
2012-09-30 $0.03B $0.11B 28.50%
2012-06-30 $0.02B $0.10B 22.16%
2012-03-31 $0.02B $0.10B 22.22%
2011-12-31 $0.02B $0.09B 23.68%
2011-09-30 $0.01B $0.08B 13.25%
2011-06-30 $0.01B $0.08B 8.33%
2011-03-31 $0.00B $0.07B 1.49%
2010-12-31 $0.00B $0.07B -3.13%
2010-09-30 $0.00B $0.07B 4.90%
2010-06-30 $0.01B $0.06B 19.05%
2010-03-31 $0.01B $0.06B 22.12%
2009-12-31 $0.01B $0.06B 13.79%
2009-09-30 $0.00B $0.05B 4.02%
2009-06-30 $0.00B $0.05B 0.00%
2009-03-31 $0.00B $0.05B -5.69%
2008-12-31 $0.00B $0.05B -3.57%
2008-09-30 $0.00B $0.06B -5.19%
2008-06-30 $-0.01B $0.06B -11.36%
2008-03-31 $-0.01B $0.06B -20.17%
2007-12-31 $-0.01B $0.06B -54.24%
2007-09-30 $-0.02B -80.00%
2007-06-30 $-0.01B -20.69%
2007-03-31 $0.00B -4.36%
2005-12-31 $0.00B $0.08B 3.25%
2005-09-30 $0.01B $0.10B 11.49%
2005-06-30 $0.01B $0.10B 12.77%
2005-03-31 $0.01B $0.09B 14.36%
2004-12-31 $0.01B $0.09B 13.75%
2004-09-30 $0.02B $0.09B 19.10%
2004-06-30 $0.01B $0.09B 12.74%
2004-03-31 $0.01B $0.08B 8.05%
2003-12-31 $0.01B $0.08B 6.97%
2003-09-30 $0.00B $0.07B 4.10%
2003-06-30 $0.01B $0.07B 9.18%
2003-03-31 $0.01B $0.07B 11.25%
2002-12-31 $0.01B $0.08B 7.08%
2002-09-30 $0.01B $0.08B 10.32%
2002-06-30 $0.01B $0.09B 11.40%
2002-03-31 $0.01B $0.09B 13.83%
2001-12-31 $0.02B $0.09B 20.42%
2001-09-30 $0.02B $0.09B 20.19%
2001-06-30 $0.02B $0.08B 20.65%
2001-03-31 $0.02B $0.08B 21.12%
2000-12-31 $0.02B $0.08B 21.12%
2000-09-30 $0.02B $0.08B 22.74%
2000-06-30 $0.02B $0.08B 22.97%
2000-03-31 $0.02B $0.08B 22.90%
1999-12-31 $0.02B $0.07B 24.32%
1999-09-30 $0.02B $0.08B 26.76%
1999-06-30 $0.02B $0.08B 29.83%
1999-03-31 $0.02B $0.07B 31.62%
1998-12-31 $0.02B $0.07B 32.06%
1998-09-30 $0.02B $0.07B 31.43%
1998-06-30 $0.02B $0.07B 31.00%
1998-03-31 $0.02B $0.07B 31.13%
1997-12-31 $0.02B $0.07B 40.43%
1997-09-30 $0.02B $0.06B 50.67%
1997-06-30 $0.02B $0.06B 79.17%
1997-03-31 $0.02B $0.00B 167.44%
1996-12-31 $0.02B $0.03B 147.83%
1996-09-30 $0.02B $0.01B 168.42%
1996-06-30 $0.01B $0.01B 155.56%
1996-03-31 $0.01B $0.00B 110.64%
1995-12-31 $0.01B $0.02B 84.21%
1995-09-30 $0.01B $0.01B 74.07%
1995-06-30 $0.01B $0.02B 66.67%
1995-03-31 $0.01B $0.01B 71.11%
1994-12-31 $0.01B $0.02B 88.89%
1994-09-30 $0.01B $0.01B 94.12%
1994-06-30 $0.01B $0.01B 91.43%
1994-03-31 $0.01B $0.01B 94.12%
1993-12-31 $0.01B $0.02B 84.85%
1993-09-30 $0.01B $0.01B 87.50%
1993-06-30 $0.01B $0.01B 96.55%
1993-03-31 $0.01B $0.00B 92.31%
1992-12-31 $0.01B $0.02B 88.89%
1992-09-30 $0.01B $0.00B 90.91%
1992-06-30 $0.00B $0.00B 84.21%
1992-03-31 $0.00B $0.01B 94.12%
1991-12-31 $0.00B $0.01B 133.33%
1991-09-30 $0.00B $0.00B 177.78%
1991-06-30 $0.00B $0.00B 177.78%
1991-03-31 $0.00B $0.00B 177.78%
1990-12-31 $0.00B $0.01B 177.78%
1990-06-30 $0.00B $0.00B 150.00%
1990-03-31 $0.00B $0.00B 200.00%
1989-09-30 $0.00B $0.00B 0.00%
1989-03-31 $0.00B $0.00B -1600.00%
1988-12-31 $0.00B $0.00B 0.00%
1988-09-30 $0.00B $0.00B -1600.00%
1988-06-30 $0.00B $0.00B -800.00%
1988-03-31 $0.00B $0.00B -400.00%
1987-12-31 $0.00B $0.00B -200.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.370B $0.454B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.048B 33.06
Zoetis (ZTS) United States $53.245B 19.06
Takeda Pharmaceutical (TAK) Japan $45.470B 9.28
BeOne Medicines - (ONC) Switzerland $43.363B 212.69
Daiichi Sankyo, - (DSNKY) Japan $42.699B 21.26
Sandoz Group AG (SDZNY) Switzerland $30.385B 0.00
United Therapeutics (UTHR) United States $20.082B 17.67
Merck (MKKGY) Germany $17.810B 10.98
Shionogi (SGIOY) Japan $14.955B 13.73
Neurocrine Biosciences (NBIX) United States $14.443B 34.66
Summit Therapeutics (SMMT) United States $13.904B 0.00
IPSEN (IPSEY) France $12.822B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.019B 0.00
Ionis Pharmaceuticals (IONS) United States $11.589B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.586B 0.00
Corcept Therapeutics (CORT) United States $7.946B 85.84
Stevanato Group S.p.A (STVN) Italy $6.687B 37.42
Grifols, S.A (GRFS) Spain $5.989B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.349B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.049B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.711B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.659B 17.37
Hypermarcas (HYPMY) Brazil $3.040B 20.87
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.849B 9.09
Dyne Therapeutics (DYN) United States $2.684B 0.00
Soleno Therapeutics (SLNO) United States $2.654B 0.00
Ocular Therapeutix (OCUL) United States $2.407B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.301B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.024B 23.98
Guardian Pharmacy Services (GRDN) United States $1.850B 35.62
Harrow (HROW) United States $1.511B 92.71
BioCryst Pharmaceuticals (BCRX) United States $1.491B 88.50
Collegium Pharmaceutical (COLL) United States $1.453B 7.20
Ardelyx (ARDX) United States $1.424B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.394B 0.00
Oruka Therapeutics (ORKA) United States $1.311B 0.00
Enliven Therapeutics (ELVN) United States $1.310B 0.00
Xeris Biopharma Holdings (XERS) United States $1.191B 0.00
Nektar Therapeutics (NKTR) United States $1.153B 0.00
Relay Therapeutics (RLAY) United States $1.090B 0.00
Evotec AG (EVO) Germany $1.074B 0.00
Xencor (XNCR) United States $1.066B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
Theravance Biopharma (TBPH) United States $0.881B 37.00
Savara (SVRA) United States $0.875B 0.00
ARS Pharmaceuticals (SPRY) United States $0.812B 0.00
Organogenesis (ORGO) United States $0.774B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.761B 6.80
Elite Pharmaceuticals (ELTP) United States $0.725B 0.00
ProKidney (PROK) United States $0.709B 0.00
Esperion Therapeutics (ESPR) United States $0.693B 0.00
KalVista Pharmaceuticals (KALV) United States $0.688B 0.00
Lexeo Therapeutics (LXEO) United States $0.660B 0.00
Aquestive Therapeutics (AQST) United States $0.658B 0.00
4D Molecular Therapeutics (FDMT) United States $0.616B 0.00
Bioventus (BVS) United States $0.608B 12.46
Ironwood Pharmaceuticals (IRWD) United States $0.510B 12.08
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Altimmune (ALT) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.430B 5.88
Lyell Immunopharma (LYEL) United States $0.359B 0.00
Galectin Therapeutics (GALT) United States $0.355B 0.00
USANA Health Sciences (USNA) United States $0.351B 9.79
Silence Therapeutics (SLN) United Kingdom $0.323B 0.00
Aldeyra Therapeutics (ALDX) United States $0.304B 0.00
Larimar Therapeutics (LRMR) United States $0.280B 0.00
Avalo Therapeutics (AVTX) United States $0.274B 0.00
Aclaris Therapeutics (ACRS) United States $0.273B 0.00
Pyxis Oncology (PYXS) United States $0.271B 0.00
Achieve Life Sciences (ACHV) Canada $0.233B 0.00
OmniAb (OABI) United States $0.225B 0.00
AleAnna (ANNA) United States $0.220B 0.00
Protara Therapeutics (TARA) United States $0.213B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.153B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.139B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Cassava Sciences (SAVA) United States $0.133B 0.00
Relmada Therapeutics (RLMD) United States $0.131B 0.00
Incannex Healthcare (IXHL) Australia $0.123B 0.00
Unicycive Therapeutics (UNCY) United States $0.122B 0.00
Avita Medical (RCEL) United States $0.114B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.111B 0.00
Context Therapeutics (CNTX) United States $0.107B 0.00
Vivani Medical (VANI) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
Karyopharm Therapeutics (KPTI) United States $0.097B 0.00
Prelude Therapeutics (PRLD) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Lite Strategy (LITS) United States $0.072B 0.00
Acrivon Therapeutics (ACRV) United States $0.071B 0.00
Plus Therapeutics (PSTV) United States $0.070B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Fractyl Health (GUTS) United States $0.063B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.058B 0.00
Korro Bio (KRRO) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.38
Liminatus Pharma (LIMN) United States $0.029B 0.00
Vyome Holdings (HIND) United States $0.027B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
Heatwurx (PCSA) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mangoceuticals (MGRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.56
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00